These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33998412)

  • 41. Iron Deficiency: A New Target for Patients With Heart Failure.
    Rizzo C; Carbonara R; Ruggieri R; Passantino A; Scrutinio D
    Front Cardiovasc Med; 2021; 8():709872. PubMed ID: 34447793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
    Mistry RH; Kohut A; Ford P
    Ann Hematol; 2021 Mar; 100(3):661-666. PubMed ID: 33169197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
    van Veldhuisen DJ; Ponikowski P; van der Meer P; Metra M; Böhm M; Doletsky A; Voors AA; Macdougall IC; Anker SD; Roubert B; Zakin L; Cohen-Solal A;
    Circulation; 2017 Oct; 136(15):1374-1383. PubMed ID: 28701470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Why and how to treat iron deficiency in heart failure ?].
    Tridetti J; Nguyen Trung ML; Ancion A; Oury C; Moonen M; Lancellotti P
    Rev Med Liege; 2020 Jan; 75(1):23-28. PubMed ID: 31920040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron deficiency and safety of ferric carboxymaltose in patients with acute heart failure. AHF-ID study.
    Jacob J; Miró Ò; Ferre C; Borraz-Ordás C; Llopis-García G; Comabella R; Fernández-Cañadas JM; Mercado A; Roset A; Richard-Espiga F; Valero-Domènech A; Martínez-Gimeno JL; Martín-Sánchez FJ; Llorens P; Berrocal-Gil P; Pérez-Durá MJ; Álvarez-Pérez JM; López-Díez P; Herrero-Puente P; Comín-Colet J
    Int J Clin Pract; 2020 Oct; 74(10):e13584. PubMed ID: 32533907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Iron deficiency : a new target in treating chronic heart failure ?].
    Borgeaud M; Perrier A
    Rev Med Suisse; 2016 Oct; 12(535):1747-1751. PubMed ID: 28692214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE-HF trial.
    Bakogiannis C; Mouselimis D; Tsarouchas A; Papadopoulos CE; Theofillogiannakos EK; Lechat E; Antoniadis AP; Pagourelias ED; Kelemanis I; Tzikas S; Fragakis N; Efthimiadis GK; Karamitsos TD; Doumas M; Vassilikos VP
    ESC Heart Fail; 2023 Apr; 10(2):1184-1192. PubMed ID: 36647691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iron deficiency in heart failure: a 2020 update.
    Tkaczyszyn M; Drozd M; Ponikowski P; Jankowska EA
    Kardiol Pol; 2019 Dec; 77(12):1134-1139. PubMed ID: 31808423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study.
    Karavidas A; Troganis E; Lazaros G; Balta D; Karavidas IN; Polyzogopoulou E; Parissis J; Farmakis D
    Eur J Heart Fail; 2021 Apr; 23(4):593-597. PubMed ID: 33421230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron deficiency as therapeutic target in heart failure: a translational approach.
    Bakogiannis C; Briasoulis A; Mouselimis D; Tsarouchas A; Papageorgiou N; Papadopoulos C; Fragakis N; Vassilikos V
    Heart Fail Rev; 2020 Mar; 25(2):173-182. PubMed ID: 31230175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
    Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
    Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.
    Grote Beverborg N; Klip IT; Meijers WC; Voors AA; Vegter EL; van der Wal HH; Swinkels DW; van Pelt J; Mulder AB; Bulstra SK; Vellenga E; Mariani MA; de Boer RA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2018 Feb; 11(2):e004519. PubMed ID: 29382661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.
    González-Costello J; Comín-Colet J
    Eur J Heart Fail; 2010 Nov; 12(11):1159-62. PubMed ID: 20855375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iron Deficiency in Heart Failure: A Korea-Oriented Review.
    Jankowska EA; Ponikowski P
    Int J Heart Fail; 2023 Oct; 5(4):173-183. PubMed ID: 37937204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iron Deficiency in Heart Failure with Reduced Ejection Fraction: Pathophysiology, Diagnosis and Treatment.
    Pereira GAR; Beck-da-Silva L
    Arq Bras Cardiol; 2022 Mar; 118(3):646-654. PubMed ID: 35319614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization.
    Mistry R; Hosoya H; Kohut A; Ford P
    Ann Hematol; 2019 Oct; 98(10):2293-2297. PubMed ID: 31402406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrospective analysis into differences in heart failure patients with and without iron deficiency or anaemia.
    Jacob C; Altevers J; Barck I; Hardt T; Braun S; Greiner W
    ESC Heart Fail; 2019 Aug; 6(4):840-855. PubMed ID: 31286685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain.
    Comín-Colet J; Rubio-Rodríguez D; Rubio-Terrés C; Enjuanes-Grau C; Gutzwiller FS; Anker SD; Ponikowski P
    Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):846-51. PubMed ID: 25649970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis.
    Vukadinović D; Abdin A; Emrich I; Schulze PC; von Haehling S; Böhm M
    Clin Res Cardiol; 2023 Jul; 112(7):954-966. PubMed ID: 37074386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency.
    Manceau H; Ausseil J; Masson D; Feugeas JP; Sablonniere B; Guieu R; Puy H; Peoc'h K
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.